Congratulations to the team at Combined Therapeutics, Inc for being awarded the 2020 North America Advance Biotech Grant grand prize of $250,000 in products, services and consultation. With a large number of applicants this year, 10 semi-finalist companies were selected to present directly to the panel of judges, from there- 3 finalist companies were selected to move forward. Two companies, Tenaya Therapeutics and Respana Therapeutics, will receive $10,000 in products and services. The Advance Biotech Grant Program is a global program that helps biotech startups understand the challenges in the quest to push the next generation of drugs to market.
“We’ve already had some really great discussions [with them]. They provided good input and helped us to give some solutions to some of the process issues that we’ve been having,” she told delegates. “This grant will help us to scale up quickly and create [nucleic acid based combined immunotherapeutics] and we look forward to continue working with them.”
You can read more about the award and hear from Combined Therapeutics, Inc’s Senior Scientist Lauren Speciner about what this award will mean for their company here.
- Congratulations Elevian! - November 23, 2021
- 2021 North America Biotech Start-up Symposium – NOW OPEN - October 20, 2021
- WEBINAR: Leveraging Next Generation Raman PAT Platform for Real-Time Bioprocess Monitoring - October 20, 2021